(Q29999056)

20 May 2017

author name string

Michael Herschel

series ordinal

1

1 reference

20 May 2017

publication date

April 2012

1 reference

20 May 2017

published in

Pharmaceutical Medicine

1 reference

20 May 2017

volume

26

1 reference

20 May 2017

page(s)

77-84

1 reference

20 May 2017

issue

2

1 reference

Can the pharmaceutical industry reduce attrition rates?

20 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Comparative prevalences of Ascaris lumbricoides, Trichuris trichiura and hookworm infections and the prospects for combined control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Trial watch: Phase II failures: 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Phase III and submission failures: 2007–2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

The influence of drug-like concepts on decision-making in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Key factors in the rising cost of new drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Strategies for optimizing combinations of molecularly targeted anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

21 January 2018

Valuation of biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Making better drugs: Decision gates in non-clinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Can open-source R&D reinvigorate drug research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Stopping clinical trials by design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

How can drug discovery for psychiatric disorders be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256895

21 January 2018

Identifiers

DOI

10.1007/BF03256895

1 reference